AB
AbCellera Biologics Inc.
Nasdaq : ABCLHealthcare · Pharmaceutical Preparations
Mkt Cap$4.09BShares Out306.61M30d Avg Vol26.61MShort Int—Short Float—IPODec 11, 2020
▼-3.18%
$23.42
No filed financial statements
AbCellera Biologics Inc. (ABCL) has not filed an annual report (Form 10-K) with the SEC, so audited financial statements aren't available yet. This is expected for recently public, private, or foreign-listed companies — figures will populate automatically once the company files. We don't show estimated or placeholder statements here.